A Phase 2b Study to Evaluate the Safety and Efficacy of VRC01 Broadly Neutralizing Monoclonal Antibody in Reducing Acquisition of HIV-1 Infection in Women in Sub-Saharan Africa: Baseline Findings
2021 · JAIDS Journal of Acquired Immune Deficiency Syndromes · 45 citations
https://doi.org/10.1097/qai.0000000000002649